Human pluripotent stem cells in pharmacological and toxicological screening: new perspectives for personalized medicine. (May 2011)

• Record Type: Journal Article
• Authors: Szebényi, Kornélia; Erdei, Zsuzsa; Péntek, Adrienn; Sebe, Attila; Orbán, Tamás I; Sarkadi, Balázs; Apáti, Ágota
• Is Part Of: Personalized medicine. Volume 8:Number 3(2011)
• Page Start: 347
• Page End: 364
• Publication Date: 2011-05
• Subjects: cardiac toxicology -- developmental screening -- developmental toxicology -- genetic manipulation of stem cells -- hepatotoxicity -- human pluripotent stem cells -- neurotoxicity -- personalized in vitro cellular systems -- pharmacological and toxicological screening -- targeted drug development; Pharmacogenomics -- Periodicals; Pharmacogenetics -- Periodicals; 615.19
• DOI: 10.2217/pme.11.19
• Languages: English
• ISSNs: 1741-0541

Abstract

Human stem cells provide an important novel tool for generating in vitro pharmacological and toxicological test systems. In the development of new targeted therapies, as well as in critical safety issues, including hepato-, neuro- and cardio-toxicity, animal-based tests are mostly unsatisfactory, whereas the use of in vitro model systems is limited by the unavailability of relevant human tissues. Human embryonic stem cell lines may fill this gap and offer an advantage over primary cultures as well as tissue-derived (adult) stem cells. Human embryonic stem cells represent an unlimited source for the production of differentiated somatic progenies and allow various stable genetic manipulations. As a new opening in personalized medicine test systems, the generation of induced pluripotent stem cell lines and their derivatives can provide patient- and disease-specific cellular assays for drug development and safety assessments. This article reviews promising human stem cell applications in pharmacological and toxicological screenings, focusing on the implications for personalized medicine.